Press release
Investigation announced for Investors in Adverum Biotechnologies, Inc. (NASDAQ: ADVM) shares over possible Violations of Securities Laws
An investigation for investors in Adverum Biotechnologies, Inc. (NASDAQ: ADVM) shares over potential securities laws violations.
Investors who purchased shares of Adverum Biotechnologies, Inc. (NASDAQ: ADVM), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Adverum Biotechnologies, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Redwood City, CA based Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, engages in developing gene therapy product candidates to treat ocular and rare diseases. ADVM-022 was intended to treat wet age-related macular degeneration ("wet AMD").
On September 12, 2019, Adverum Biotechnologies, Inc disclosed that patients taking the drug in the study suffered significant deterioration in their sight.
Shares of Adverum Biotechnologies, Inc. (NASDAQ: ADVM) declined from $16.38 per share in July 2019 to as low as $5.10 per share in October 2019.
Those who purchased shares of Adverum Biotechnologies, Inc. (NASDAQ: ADVM) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in Adverum Biotechnologies, Inc. (NASDAQ: ADVM) shares over possible Violations of Securities Laws here
News-ID: 1946567 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Adverum
Vectorized Antibodies Market Size, Scope 2031 by Key Companies- 4D Molecular The …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲: According to Verified Market Reports analysis, the global Vectorized Antibodies Market size is reached a valuation of USD 7.8 Billion in 2023, with projections to achieve USD 177.78 Billion by 2031, demonstrating a 𝐂𝐀𝐆𝐑44.2% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟏.
The vectorized antibodies market presents significant opportunities, driven by the growing demand for targeted therapies and advancements in biotechnology. Vectorized antibodies, which use engineered viral vectors to enhance the delivery…
Diabetic Macular Edema Market to Observe Stupendous Growth During the Forecast P …
Diabetic Macular Edema (DME) Market size in the 7MM (i.e., the United States, EU4 (Germany, Spain, Italy, France), the UK and Japan) was found to be ~USD 2.9 billion in 2021.
Diabetic Macular Edema Market is anticipated to grow in the coming years owing to the growing awareness, improved management, and better outcomes with emerging therapies. Moreover, the increase in the diabetic population, a rise in the number of healthcare expenditures,…
Macular Degeneration Drug Market Brief Analysis of Top Leading Companies From 20 …
"Worldwide Market Reports offers 𝐔𝐩𝐭𝐨 𝟕𝟎% 𝐝𝐢𝐬𝐜𝐨𝐮𝐧𝐭 on Macular Degeneration Drug Market Reports on Single User Access and Unlimited User Access"
Macular Degeneration Drug Market report discusses everything a marketer requires before investing in the global Macular Degeneration Drug during the forecast period 2023-2030. It provides detailed insight into current trends, market shares, market size, and sales value and volume. The data used for this report is obtained from reliable industry…
Friedreich Ataxia Drug Market to Witness Growth Acceleration | Adverum Biotechno …
Friedreich Ataxia Drug Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The report answers questions on the current and future technological advancements and development. It delivers an analysis of main manufactures and geographic regions.
The global Friedreich Ataxia Drug market is segmented by company, region (country), type, application, players, stakeholders, and others. The report includes the opportunities and encounters that are faced by…
Targeted Delivery Drugs Market Advancements and Outlook 2021 to 2026 : Adverum, …
Global Targeted Delivery Drugs Market Size, Status and Forecast 2021-2027
The report begins with the overview of the Targeted Delivery Drugs Market and offers throughout development. It presents a comprehensive analysis of all the regional and major player segments that gives closer insights upon present market conditions and future market opportunities along with drivers, trending segments, consumer behaviour, pricing factors and market performance and estimation. The forecast market information, SWOT analysis,…
Gene Therapy Products Market 2020-2026 Shows Strong Growth || Leading Players - …
By working with a number of steps of collecting and analysing market data, this finest Gene Therapy Products market research report is framed with the expert team. Being an outstanding resource of market info, the Gene Therapy Products Market report provides recent as well as upcoming technical and financial details of the industry. The market study and analysis of this business report also lends a hand to figure out types…
